Synergetics USA (NASDAQ: SURG) and Illumina (NASDAQ:ILMN) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability.
This table compares Synergetics USA and Illumina’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of recent recommendations and price targets for Synergetics USA and Illumina, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Illumina has a consensus price target of $213.71, suggesting a potential downside of 12.67%.
Valuation and Earnings
This table compares Synergetics USA and Illumina’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Illumina||$2.40 billion||14.90||$462.64 million||$5.30||46.17|
Illumina has higher revenue and earnings than Synergetics USA. Synergetics USA is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
91.6% of Illumina shares are held by institutional investors. 0.9% of Illumina shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Illumina beats Synergetics USA on 8 of the 8 factors compared between the two stocks.
Synergetics USA Company Profile
Synergetics USA, Inc., formerly Valley Forge Scientific Corp., is a supplier of precision surgical devices. The Company focuses on the surgical disciplines of ophthalmology and neurosurgery. It offers precision engineered disposable and reusable devices, surgical equipment and surgical procedural kits. It also delivers energy modalities for the performance of surgery, including laser energy, ultrasonic energy, radio frequency energy for electro surgery and lesion generation, visible light energy for illumination and simultaneous infusion (irrigation) of fluids into the operative field. Its products include VersaVIT 2.0 Vitrectomy System, Directional II Laser Probe and Pinnacle 360�. It offers its products under the brand names: VersaPACK, Core Essentials, Photon, Solitaire, Volk’s and Labtician’s, among others. It offers approximately 1,000 separate catalogue items in the vitreoretinal surgical market. It sells its products in approximately 60 countries outside the United States.
Illumina Company Profile
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company’s portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.
What are top analysts saying about Synergetics USA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Synergetics USA and related companies.